142 related articles for article (PubMed ID: 11906774)
41. Comparison of the immunogenicity and efficacy of a replication-defective vaccinia virus expressing antigens of human parainfluenza virus type 3 (HPIV3) with those of a live attenuated HPIV3 vaccine candidate in rhesus monkeys passively immunized with PIV3 antibodies.
Durbin AP; Cho CJ; Elkins WR; Wyatt LS; Moss B; Murphy BR
J Infect Dis; 1999 Jun; 179(6):1345-51. PubMed ID: 10228053
[TBL] [Abstract][Full Text] [Related]
42. Recent developments with live-attenuated recombinant paramyxovirus vaccines.
Le Bayon JC; Lina B; Rosa-Calatrava M; Boivin G
Rev Med Virol; 2013 Jan; 23(1):15-34. PubMed ID: 22570186
[TBL] [Abstract][Full Text] [Related]
43. Mutations in the C, D, and V open reading frames of human parainfluenza virus type 3 attenuate replication in rodents and primates.
Durbin AP; McAuliffe JM; Collins PL; Murphy BR
Virology; 1999 Sep; 261(2):319-30. PubMed ID: 10497117
[TBL] [Abstract][Full Text] [Related]
44. African green monkeys provide a useful nonhuman primate model for the study of human parainfluenza virus types-1, -2, and -3 infection.
Durbin AP; Elkins WR; Murphy BR
Vaccine; 2000 May; 18(22):2462-9. PubMed ID: 10738104
[TBL] [Abstract][Full Text] [Related]
45. Genetic stability of RSV-F expression and the restricted growth phenotype of a live attenuated PIV3 vectored RSV vaccine candidate (MEDI-534) following restrictive growth in human lung cells.
Nelson CL; Tang RS; Stillman EA
Vaccine; 2013 Aug; 31(36):3756-62. PubMed ID: 23623857
[TBL] [Abstract][Full Text] [Related]
46. A host-range restricted parainfluenza virus type 3 (PIV3) expressing the human metapneumovirus (hMPV) fusion protein elicits protective immunity in African green monkeys.
Tang RS; Mahmood K; Macphail M; Guzzetta JM; Haller AA; Liu H; Kaur J; Lawlor HA; Stillman EA; Schickli JH; Fouchier RA; Osterhaus AD; Spaete RR
Vaccine; 2005 Feb; 23(14):1657-67. PubMed ID: 15705469
[TBL] [Abstract][Full Text] [Related]
47. Role of interferon in the replication of human parainfluenza virus type 1 wild type and mutant viruses in human ciliated airway epithelium.
Bartlett EJ; Hennessey M; Skiadopoulos MH; Schmidt AC; Collins PL; Murphy BR; Pickles RJ
J Virol; 2008 Aug; 82(16):8059-70. PubMed ID: 18524813
[TBL] [Abstract][Full Text] [Related]
48. Murine Pneumonia Virus Expressing the Fusion Glycoprotein of Human Respiratory Syncytial Virus from an Added Gene Is Highly Attenuated and Immunogenic in Rhesus Macaques.
Brock LG; Liu X; Liang B; Lingemann M; Liu X; Herbert R; Hackenberg AD; Buchholz UJ; Collins PL; Munir S
J Virol; 2018 Sep; 92(17):. PubMed ID: 29925656
[TBL] [Abstract][Full Text] [Related]
49. Attenuation of the recombinant human parainfluenza virus type 3 cp45 candidate vaccine virus is augmented by importation of the respiratory syncytial virus cpts530 L polymerase mutation.
Skiadopoulos MH; Surman SR; St Claire M; Elkins WR; Collins PL; Murphy BR
Virology; 1999 Jul; 260(1):125-35. PubMed ID: 10405364
[TBL] [Abstract][Full Text] [Related]
50. Recombinant newcastle disease virus expressing a foreign viral antigen is attenuated and highly immunogenic in primates.
Bukreyev A; Huang Z; Yang L; Elankumaran S; St Claire M; Murphy BR; Samal SK; Collins PL
J Virol; 2005 Nov; 79(21):13275-84. PubMed ID: 16227250
[TBL] [Abstract][Full Text] [Related]
51. Chimeric bovine respiratory syncytial virus with glycoprotein gene substitutions from human respiratory syncytial virus (HRSV): effects on host range and evaluation as a live-attenuated HRSV vaccine.
Buchholz UJ; Granzow H; Schuldt K; Whitehead SS; Murphy BR; Collins PL
J Virol; 2000 Feb; 74(3):1187-99. PubMed ID: 10627529
[TBL] [Abstract][Full Text] [Related]
52. Recombinant chimeric yellow fever-dengue type 2 virus is immunogenic and protective in nonhuman primates.
Guirakhoo F; Weltzin R; Chambers TJ; Zhang ZX; Soike K; Ratterree M; Arroyo J; Georgakopoulos K; Catalan J; Monath TP
J Virol; 2000 Jun; 74(12):5477-85. PubMed ID: 10823852
[TBL] [Abstract][Full Text] [Related]
53. The aberrant gene-end transcription signal of the matrix M gene of human parainfluenza virus type 3 downregulates fusion F protein expression and the F-specific antibody response in vivo.
Lingemann M; Surman S; Amaro-Carambot E; Schaap-Nutt A; Collins PL; Munir S
J Virol; 2015 Mar; 89(6):3318-31. PubMed ID: 25589643
[TBL] [Abstract][Full Text] [Related]
54. Evaluation of recombinant respiratory syncytial virus gene deletion mutants in African green monkeys for their potential as live attenuated vaccine candidates.
Jin H; Cheng X; Traina-Dorge VL; Park HJ; Zhou H; Soike K; Kemble G
Vaccine; 2003 Sep; 21(25-26):3647-52. PubMed ID: 12922094
[TBL] [Abstract][Full Text] [Related]
55. Progress in the development of human parainfluenza virus vaccines.
Schmidt AC; Schaap-Nutt A; Bartlett EJ; Schomacker H; Boonyaratanakornkit J; Karron RA; Collins PL
Expert Rev Respir Med; 2011 Aug; 5(4):515-26. PubMed ID: 21859271
[TBL] [Abstract][Full Text] [Related]
56. Human parainfluenza virus type 3 (PIV3) expressing the hemagglutinin protein of measles virus provides a potential method for immunization against measles virus and PIV3 in early infancy.
Durbin AP; Skiadopoulos MH; McAuliffe JM; Riggs JM; Surman SR; Collins PL; Murphy BR
J Virol; 2000 Aug; 74(15):6821-31. PubMed ID: 10888621
[TBL] [Abstract][Full Text] [Related]
57. Enhanced Neutralizing Antibody Response Induced by Respiratory Syncytial Virus Prefusion F Protein Expressed by a Vaccine Candidate.
Liang B; Surman S; Amaro-Carambot E; Kabatova B; Mackow N; Lingemann M; Yang L; McLellan JS; Graham BS; Kwong PD; Schaap-Nutt A; Collins PL; Munir S
J Virol; 2015 Sep; 89(18):9499-510. PubMed ID: 26157122
[TBL] [Abstract][Full Text] [Related]
58. Human parainfluenza virus type 1 C proteins are nonessential proteins that inhibit the host interferon and apoptotic responses and are required for efficient replication in nonhuman primates.
Bartlett EJ; Cruz AM; Esker J; Castaño A; Schomacker H; Surman SR; Hennessey M; Boonyaratanakornkit J; Pickles RJ; Collins PL; Murphy BR; Schmidt AC
J Virol; 2008 Sep; 82(18):8965-77. PubMed ID: 18614629
[TBL] [Abstract][Full Text] [Related]
59. Sequence analysis of the Washington/1964 strain of human parainfluenza virus type 1 (HPIV1) and recovery and characterization of wild-type recombinant HPIV1 produced by reverse genetics.
Newman JT; Surman SR; Riggs JM; Hansen CT; Collins PL; Murphy BR; Skiadopoulos MH
Virus Genes; 2002; 24(1):77-92. PubMed ID: 11928991
[TBL] [Abstract][Full Text] [Related]
60. Parainfluenza virus type 3 expressing the native or soluble fusion (F) Protein of Respiratory Syncytial Virus (RSV) confers protection from RSV infection in African green monkeys.
Tang RS; MacPhail M; Schickli JH; Kaur J; Robinson CL; Lawlor HA; Guzzetta JM; Spaete RR; Haller AA
J Virol; 2004 Oct; 78(20):11198-207. PubMed ID: 15452239
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
